anti-IgM antibody product blog
Tags: Antibody; IgM; Monoclonal Antibody; anti-IgM antibody;
The IgM n/a (Catalog #MBS224450) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s IgM can be used in a range of immunoassay formats including, but not limited to, Immunohistology Frozen, Flow cytometry (FC/FACS).Flow Cytometry: Use 10ul of the suggested working dilution to label 1x106 cells in 100ul. Researchers should empirically determine the suitability of the IgM n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The IgM n/a product has the following accession number(s) (GI #127511) (NCBI Accession #P04221.2). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse anti Rabbit IgM (B Cell Marker) antibody, clone NRBM specifically recognizes the m chain of rabbit Ig. By flow cytometric analysis NRBM has been shown to label B cells.
Perservative Stabilisers: 0.09% Sodium Azide (NaN3)
Preparation: Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant. Buffer Solution: Phosphate buffered saline
Target Species: Rabbit. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IgM are readily searchable from our website. Different antibodies against the same target such as IgM may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.